[
  {
    "ts": null,
    "headline": "EW Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corporation",
    "summary": "RADNOR, Pa., Dec. 4, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP  informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences...",
    "url": "https://finnhub.io/api/news?id=4a818303695b5fb6536b66102e0c3cf4ce06397584c94b5bc97bc805bfa1e26e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733338864,
      "headline": "EW Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corporation",
      "id": 131771380,
      "image": "",
      "related": "EW",
      "source": "Finnhub",
      "summary": "RADNOR, Pa., Dec. 4, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP  informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences...",
      "url": "https://finnhub.io/api/news?id=4a818303695b5fb6536b66102e0c3cf4ce06397584c94b5bc97bc805bfa1e26e"
    }
  },
  {
    "ts": null,
    "headline": "EW DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important December 13 Deadline in Securities Class Action - EW",
    "summary": "WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation between February 6, 2024 and July 24, 2024, both dates inclusive , of the...",
    "url": "https://finnhub.io/api/news?id=0d37a4858218b1c674f22e934a7a6249e4834f3d4bbe8bfd6a69c666421ad0f2",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733331843,
      "headline": "EW DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important December 13 Deadline in Securities Class Action - EW",
      "id": 131770139,
      "image": "",
      "related": "EW",
      "source": "Finnhub",
      "summary": "WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation between February 6, 2024 and July 24, 2024, both dates inclusive , of the...",
      "url": "https://finnhub.io/api/news?id=0d37a4858218b1c674f22e934a7a6249e4834f3d4bbe8bfd6a69c666421ad0f2"
    }
  },
  {
    "ts": null,
    "headline": "Edwards Lifesciences Corp. stock outperforms competitors on strong trading day",
    "summary": "Edwards Lifesciences Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=b916360dde5c213160d091d5326865f9bef6eec87ca9679b8fc617e2ea21d0e1",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733331420,
      "headline": "Edwards Lifesciences Corp. stock outperforms competitors on strong trading day",
      "id": 131784037,
      "image": "",
      "related": "EW",
      "source": "MarketWatch",
      "summary": "Edwards Lifesciences Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=b916360dde5c213160d091d5326865f9bef6eec87ca9679b8fc617e2ea21d0e1"
    }
  },
  {
    "ts": null,
    "headline": "Edwards Lifesciences Outlines Vision For Growth At Investor Conference",
    "summary": "On Wednesday, during its annual investor conference, Edwards Lifesciences Corporation (NYSE:EW) detailed its strategy for sustained long-term growth and innovations in structural heart therapies. The company, now exclusively focused on structural heart solutions, emphasized its robust technology pipeline, financial guidance, and expanding opportunities in Transcatheter Aortic Valve Replacement (TAVR) and Transcatheter Mitral and Tricuspid Therapies (TMTT). Also Read: Morgan Stanley Maintains Pos",
    "url": "https://finnhub.io/api/news?id=c20cc603ccd54fe628faf5212b328aa2c862be453ad1dc7dffd7890c7ec71b68",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733330456,
      "headline": "Edwards Lifesciences Outlines Vision For Growth At Investor Conference",
      "id": 131770581,
      "image": "https://media.zenfs.com/en/Benzinga/0fa6fc6dccabc89762cc64000bdf087d",
      "related": "EW",
      "source": "Yahoo",
      "summary": "On Wednesday, during its annual investor conference, Edwards Lifesciences Corporation (NYSE:EW) detailed its strategy for sustained long-term growth and innovations in structural heart therapies. The company, now exclusively focused on structural heart solutions, emphasized its robust technology pipeline, financial guidance, and expanding opportunities in Transcatheter Aortic Valve Replacement (TAVR) and Transcatheter Mitral and Tricuspid Therapies (TMTT). Also Read: Morgan Stanley Maintains Pos",
      "url": "https://finnhub.io/api/news?id=c20cc603ccd54fe628faf5212b328aa2c862be453ad1dc7dffd7890c7ec71b68"
    }
  },
  {
    "ts": null,
    "headline": "EW Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Edwards Lifescience Corporation (EW) Investors of Deadline and Encourages Investors with Losses to Contact the Firm",
    "summary": "- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation on behalf of investors who...",
    "url": "https://finnhub.io/api/news?id=dee9bdf0f884a6ecea6be96f0acdf9b002c59cec5c5848b6aa88c90dbd3bd54a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733317446,
      "headline": "EW Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Edwards Lifescience Corporation (EW) Investors of Deadline and Encourages Investors with Losses to Contact the Firm",
      "id": 131768180,
      "image": "",
      "related": "EW",
      "source": "Finnhub",
      "summary": "- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation on behalf of investors who...",
      "url": "https://finnhub.io/api/news?id=dee9bdf0f884a6ecea6be96f0acdf9b002c59cec5c5848b6aa88c90dbd3bd54a"
    }
  },
  {
    "ts": null,
    "headline": "Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference",
    "summary": "NEW YORK, December 04, 2024--Edwards Lifesciences Corporation (NYSE: EW) will discuss the company’s focused strategy for long-term sustainable growth, provide an update on its technology pipeline to serve more patients and share financial guidance today during its annual investor conference. Edwards enters 2025, its first full year as a purely structural heart company, in a strong position with major growth drivers in Transcatheter Aortic Valve Replacement (TAVR) and Transcatheter Mitral and Tri",
    "url": "https://finnhub.io/api/news?id=3670f0aa6e462ea7e13fc771621853b624562c57d75f679e55994731b48ff481",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733310000,
      "headline": "Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference",
      "id": 131770582,
      "image": "https://media.zenfs.com/en/business-wire.com/f8ab201225ff8d21d78c580af111957b",
      "related": "EW",
      "source": "Yahoo",
      "summary": "NEW YORK, December 04, 2024--Edwards Lifesciences Corporation (NYSE: EW) will discuss the company’s focused strategy for long-term sustainable growth, provide an update on its technology pipeline to serve more patients and share financial guidance today during its annual investor conference. Edwards enters 2025, its first full year as a purely structural heart company, in a strong position with major growth drivers in Transcatheter Aortic Valve Replacement (TAVR) and Transcatheter Mitral and Tri",
      "url": "https://finnhub.io/api/news?id=3670f0aa6e462ea7e13fc771621853b624562c57d75f679e55994731b48ff481"
    }
  },
  {
    "ts": null,
    "headline": "EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm",
    "summary": "LOS ANGELES, Dec. 4, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ...",
    "url": "https://finnhub.io/api/news?id=0f71c6e30a7fbb30b0a93d014745f02a4f0188f177b0428502e57d3c7176c997",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733306469,
      "headline": "EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm",
      "id": 131766768,
      "image": "",
      "related": "EW",
      "source": "Finnhub",
      "summary": "LOS ANGELES, Dec. 4, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ...",
      "url": "https://finnhub.io/api/news?id=0f71c6e30a7fbb30b0a93d014745f02a4f0188f177b0428502e57d3c7176c997"
    }
  },
  {
    "ts": null,
    "headline": "Edwards Lifesciences : 2024 Investor Conference",
    "summary": "Edwards Lifesciences 2024 Investor Conference 2024 Investor Conference ...",
    "url": "https://finnhub.io/api/news?id=a6c4040644558f8607dadd6af45564552d50e7fdcf31af0bf6b727fad0feb086",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733301248,
      "headline": "Edwards Lifesciences : 2024 Investor Conference",
      "id": 131766066,
      "image": "",
      "related": "EW",
      "source": "Finnhub",
      "summary": "Edwards Lifesciences 2024 Investor Conference 2024 Investor Conference ...",
      "url": "https://finnhub.io/api/news?id=a6c4040644558f8607dadd6af45564552d50e7fdcf31af0bf6b727fad0feb086"
    }
  }
]